http://investorshangout.com/post/view?id=2380001
Post# of 30028
Seems like "The Real" list is getting checked off.
Also,
By the end of 2014 the Company anticipates :
Filing an orphan drug designation application with the FDA for MANF in Retinitis Pigmentosa and immediately thereafter will be submitting a second ocular orphan drug application for MANF with the FDA
http://www.thechairmansblog.com/amarantus-bio...-strength/